Cannabis Suisse (Cannabis Suisse) Debt-to-EBITDA : -3.70 (As of Feb. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cannabis Suisse Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cannabis Suisse's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2024 was $0.32 Mil. Cannabis Suisse's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2024 was $0.59 Mil. Cannabis Suisse's annualized EBITDA for the quarter that ended in Feb. 2024 was $-0.25 Mil. Cannabis Suisse's annualized Debt-to-EBITDA for the quarter that ended in Feb. 2024 was -3.70.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Cannabis Suisse's Debt-to-EBITDA or its related term are showing as below:

CSUI' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -3.92 Med: -0.51 Max: -0.2
Current: -3.92

During the past 8 years, the highest Debt-to-EBITDA Ratio of Cannabis Suisse was -0.20. The lowest was -3.92. And the median was -0.51.

CSUI's Debt-to-EBITDA is ranked worse than
100% of 661 companies
in the Drug Manufacturers industry
Industry Median: 1.7 vs CSUI: -3.92

Cannabis Suisse Debt-to-EBITDA Historical Data

The historical data trend for Cannabis Suisse's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Suisse Debt-to-EBITDA Chart

Cannabis Suisse Annual Data

Trend

May16

May17

May18

May19

May20

May21

May22

May23

Debt-to-EBITDA

Get a 7-Day Free Trial

-0.24

-0.51

-0.20

-1.11

-1.41

Cannabis Suisse Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Debt-to-EBITDA	Get a 7-Day Free Trial															-0.98	-1.92	-2.64	-3.00	-3.70

Competitive Comparison of Cannabis Suisse's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Suisse's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Suisse's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Suisse's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cannabis Suisse's Debt-to-EBITDA falls into.

Cannabis Suisse Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cannabis Suisse's Debt-to-EBITDA for the fiscal year that ended in May. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.135	+	0.342)	/	-0.338
	=	-1.41

Cannabis Suisse's annualized Debt-to-EBITDA for the quarter that ended in Feb. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.324	+	0.593)	/	-0.248
	=	-3.70

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Feb. 2024) EBITDA data.

Cannabis Suisse (OTCPK:CSUI) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Cannabis Suisse Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cannabis Suisse's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.